The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media-Related Antibiotic Use Among Young Children in Tennessee, USA

被引：4
|
作者：
Griffith, Hannah [1 ]
Wiese, Andrew D. [1 ]
Mitchel, Edward F., Jr. [1 ]
Grijalva, Carlos G. [1 ,2 ]
机构：
[1] Vanderbilt Univ, Dept Hlth Policy, Med Ctr, Nashville, TN USA
[2] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2022年 / 9卷 / 03期
基金：
美国国家卫生研究院;
关键词：
otitis media; antibiotic use; pneumococcal conjugate vaccines; HEALTH-CARE UTILIZATION; ANTIMICROBIAL RESISTANCE; CHILDHOOD IMMUNIZATION; PNEUMONIA; HOSPITALIZATIONS; ADMISSIONS; DIAGNOSIS;
D O I：
10.1093/ofid/ofac019
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the OM-related antibiotic fill rate was stable after PCV13 introduction.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children
    Turner, Paul
    Leab, Phana
    Ly, Sokeng
    Sao, Sena
    Miliya, Thyl
    Heffelfinger, James D.
    Batmunkh, Nyambat
    Lessa, Fernanda C.
    Walldorf, Jenny A.
    Hyde, Terri B.
    Ork, Vichit
    Hossain, Shafiqul
    Gould, Katherine A.
    Hinds, Jason
    Cooper, Ben S.
    Ngoun, Chanpheaktra
    Turner, Claudia
    Day, Nicholas P. J.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1580 - 1588
  • [22] National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States
    Zhou, Xiaofeng
    de Luise, Cynthia
    Gaffney, Michael
    Burt, Catharine W.
    Scott, Daniel A.
    Gatto, Nicolle
    Center, Kimberly J.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2019, 119 : 96 - 102
  • [23] 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Infants, Children, and Adolescents
    Greg L. Plosker
    Pediatric Drugs, 2013, 15 : 403 - 423
  • [24] 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Infants, Children, and Adolescents
    Plosker, Greg L.
    PEDIATRIC DRUGS, 2013, 15 (05) : 403 - 423
  • [25] Comments about the article: "Impact of the 13-valent pneumococcal conjugate vaccine"
    Panattieri, Nestor D.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2016, 114 (06): : E486 - E486
  • [26] Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia
    Urbancikova, Ingrid
    Prymula, Roman
    Goldblatt, David
    Roalfe, Lucy
    Prymulova, Karolina
    Kosina, Pavel
    VACCINE, 2017, 35 (38) : 5186 - 5193
  • [27] The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly
    van Werkhoven, Cornelis H.
    Huijts, Susanne M.
    Bolkenbaas, Marieke
    Grobbee, Diederick E.
    Bonten, Marc J. M.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (12) : 1835 - 1838
  • [28] Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine
    Frenck, Robert, Jr.
    Thompson, Allison
    Yeh, Sylvia H.
    London, Arnold
    Sidhu, Mohinder S.
    Patterson, Scott
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    Gurtman, Alejandra
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : 1086 - 1091
  • [29] 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Plosker, Greg L.
    DRUGS, 2015, 75 (13) : 1535 - 1546
  • [30] 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Greg L. Plosker
    Drugs, 2015, 75 : 1535 - 1546
12345